The Strontium Chloride 89 (SR89) injection has been approved by the FDA and is a non-opioid injection to relieve bone pain in patients with painful skeletal metastases.
Clinical studies showed the combination of alternating weekly chemohormonal therapies with Strontium-89 demonstrated a prolonged progression-free and overall survival in patients.
The website is at http://www.PainFreeCancer.com.
In the body, Strontium-89 acts in a similar way to calcium and is preferentially taken up in osteoblastic tissue selectively localizing in bone.
Q BioMed shares added 2.13% to US$3.83 each.